Schonfeld Strategic Advisors LLC Day One Biopharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 244,957 shares of DAWN stock, worth $3.54 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
244,957
Previous 237,748
3.03%
Holding current value
$3.54 Million
Previous $3.93 Million
14.06%
% of portfolio
0.02%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding DAWN
# of Institutions
165Shares Held
71.9MCall Options Held
163KPut Options Held
183K-
Ra Capital Management, L.P. Boston, MA7.87MShares$114 Million1.63% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$93 Million11.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$66.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$65.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.78MShares$54.7 Million0.02% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.06B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...